ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD30 Antibody [MEM-268] (Alexa Fluor® 647) (A18739)

This product is discontinued

Anti-CD30 Antibody [MEM-268] (Alexa Fluor® 647) (A18739) has been discontinued and is no longer available.

View all available products.

Name
Anti-CD30 Antibody [MEM-268] (Alexa Fluor® 647)
Description
Mouse monoclonal [MEM-268] antibody to CD30 (Alexa Fluor® 647).
Specificity
This antibody recognizes extracellular part of CD30, a 105 kDa single chain glycoprotein expressed on Hodgkin's and Reed-Sternberg cells. It is also found in Burkitt's lymphomas, virus-infected T and B lymphocytes, and on normal B and T lymphocytes after activation (T lymphocytes that produce Th2-type cytokines and on CD4+/CD8+ T lymphocytes that co-express CD45RO and the IL4 receptor).
Applications
Flow Cytometry
Dilutions
Flow Cytometry: This reagent is designed for analysis of human blood cells using 4µl reagent / 100µl of whole blood or 106 cells in a suspension.
Reactivity
Human
Immunogen
Expression vector containing CD30 cDNA (booster suspension of THP-1 cell line).
Host
Mouse
Clonality
Monoclonal
Clone ID
MEM-268
Isotype
IgG
Conjugate

Alexa Fluor® 647

Excitation: 650nm, Emission: 665nm

Purification
This antibody is conjugated with Alexa Fluor® 647 under optimum conditions. The conjugate is purified by size-exclusion chromatography.
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 15mM Sodium Azide.
Storage
Store in the dark at 2-8°C. Do not freeze!
Synonyms
CD30L receptor, D1S166E, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, Tumor necrosis factor receptor superfamily member 8
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.

Proteins predicted to interact with CD30

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99% Relevancy Score
98.6% Relevancy Score
96.9% Relevancy Score
95.5% Relevancy Score
95.2% Relevancy Score
94.1% Relevancy Score
93.4% Relevancy Score
92.2% Relevancy Score